AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06465771 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Youth-led NCD risk reduction intervention
Description: With the help of Youth (students of grades 9 and 10), their parents and other stakeholders, including teachers, headteachers, and canteen staff through qualitative interviews, we will develop an intervention focuses on NCD risk reduction among younger peers (students of grades 5 and 6). A nutritionist will train the youth on how to deliver the intervention among their younger peers.
Study NCT06171516 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: iCBT
Description: All participants will undergo 10 guided therapy sessions (once-weekly) with each session lasting 20 minutes. The therapy module will be given as an online self-learning source via videos in a website specifically developed for this training. The videos will divide the module content into several parts with each video lasting about 10 minutes.
Study NCT04699370 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: cognition-targeted exercise
Description: All Standardized physical therapy exercises will be performed in a time-contingent .~Goal setting is essentially done together with the patient, focussing on functionality instead of fatigue relief. Progression to a next level of (more difficult) exercises will be preceded by an intermediate phase of motor imagery.~The treating physical therapist will be advised to address patients' cognitions about their problems during the cognition-targeted exercise training, so that patients will have positive perceptions regarding their illness and treatment outcome.~The treating physical therapist will be advised to discuss the patient's perceptions about each exercise. This include discussion of the anticipated consequences of the exercises and challenging the patient's cognitions in relation to the exercises
Study NCT04699370 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy
Description: In the first and second sessions, patients will learn about fatigue-related symptoms as well as Cognitive behavioral therapy and its effectiveness. The third and fourth sessions will be devoted on the introduction of behavioral strategies. The fifth session will introduce cognitive strategies to decrease fatigue. The last three sessions will be about how to adopt the proposed strategies consistently.
Study NCT04699370 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive behavioral therapy
Description: In the first and second sessions, patients will learn about fatigue-related symptoms as well as Cognitive behavioral therapy and its effectiveness. The third and fourth sessions will be devoted on the introduction of behavioral strategies. The fifth session will introduce cognitive strategies to decrease fatigue. The last three sessions will be about how to adopt the proposed strategies consistently.
Study NCT04699370 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standardized physical therapy
Description: The standardized physical therapy will consist of eight half-hour individualized face to face physiotherapy sessions, over a 4-week period. this program will consist of twice-weekly supervised general aerobic, strengthening and flexibility exercise sessions .This exercise program is reflective of the general exercises typically undertaken within routine clinical practice.
Study NCT06054945 — intervention group
Intervention type: PROCEDURE
Intervention: SIFIB (suprainguinal fascia iliaca block)
Description: Ultrasound guided Suprainguinal Fascia Iliaca Block for Knee Arthroplasty Patients
Study NCT06054945 — intervention group
Intervention type: OTHER
Intervention: IPACK (Interspace between the popliteal artery and capsule of the posterior knee )
Description: Ultrasound guided IPACK (Interspace between the popliteal artery and capsule of the posterior knee ) Block for Knee Arthroplasty Patients
Study NCT06054945 — intervention group
Intervention type: DEVICE
Intervention: Patient controlled anagesia device
Description: Those who were administered opioids with PCA as rescue analgesic in the postoperative analgesia plan on the selected dates will be included in the study.
Study NCT04399343 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Dexmedetomidine hydrochloride (200 μg/2 ml) is diluted with normal saline to 50 ml and is continuously intravenous infused at a rate of 0.025 ml/kg/hour (dexmedetomidine 0.1 μg/kg/hour). The intravenous infusion begins immediately after enrollment until 08:00 AM on the postoperative day one.
Study NCT04399343 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: Normal saline is also diluted with normal saline to 50 ml and is continuously intravenous infused at a rate of 0.025 ml/kg/hour, which is the same with the dexmedetomidine group. The intravenous infusion begins immediately after enrollment until 08:00 AM on the postoperative day one.
Study NCT04650399 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Active
Description: Single intramuscular vaccination on Day 1 with VLA1553, a lyophilized live-attenuated Chikungunya vaccine candidate 1x10E4 TCID50 per dose
Study NCT04650399 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single intramuscular vaccination on Day 1 with Phosphate-Buffered Saline (PBS) as placebo
Study NCT05438836 — intervention group
Intervention type: RADIATION
Intervention: online adaptive radiotherapy
Description: Online adaptive radiotherapy compared to standard non-adaptive Image-Guided Radiotherapy
Study NCT04821817 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: peribulbar anesthesia with 10 ml local anesthetic mixture composed of 4 ml of plain bupivacaine 0.5%, 4 ml of lidocaine 2% containing 50 IU, and 2 ml normal saline.
Study NCT04821817 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rocuronium
Description: peribulbar anesthesia with 10 ml local anesthetic mixture composed of 4 ml of plain bupivacaine 0.5%, 4 ml of lidocaine 2% containing 50 IU, and 0.06 mg/kg of rocuronium in 2 ml normal saline.
Study NCT05535426 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tetranite Implant Stabilization Material
Description: Dental adhesive for increased implant stabilization
Study NCT05030051 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SkinPen Precision System
Description: Microneedling is a relatively new, minimally invasive technique originally developed for skin rejuvenation. Controlled micro-injury to the dermis via the application of several small needles connected to a motorized device stimulates the wound healing process, resulting in the formation of new tissue and blood vessels. The SkinPen by Crown Laboratories is an FDA-cleared microneedling device proven to improve the appearance of acne scars This study evaluates the clinical performance of the SkinPen device for the treatment of signs of aging on the back of the hand. We hypothesize that the SkinPen device will produce a significant improvement in dorsal hand appearance at 3 month post treatment visit, when compared with baseline scores. The assessments will be based on the Clinician's Global Aesthetic Improvement Scale, and the Subject's Global Aesthetic Improvement Scale at the 3 month post treatment visit.
Study NCT06020950 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Low-calorie diet with the use of placebo pearls (containing sunflower oil)
Study NCT06020950 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Omega-3 supplementation
Description: Low-calorie diet with the use of marine omega-3 pearls (containing 1200 mg eicosapentaenoic acid + 600 mg docosahexaenoic acid/day)
Study NCT06020950 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chia seed
Description: Low-calorie diet with the consumption of 30 grams of powdered chia seeds
Study NCT05266703 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Isotopically labelled iron sulfate 15mg
Description: test drink: water containing isotopic iron solution with vitamin C
Study NCT05602753 — intervention group
Intervention type: BEHAVIORAL
Intervention: Lifestyle Counseling
Description: Referring to Stop smoking hotline, given pamphlets to encourage quitting smoking, pharmacy guidance, and possible referral to smoking cessation clinic.
Study NCT05097391 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Warm-up (5 minutes)
Description: Participants will benefit from passive stretches of hamstrings, calf muscles including a range of motion (ROM) exercise to the lower limbs as mat exercises.
Study NCT05097391 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Warm-up (5 minutes)
Description: Participants will benefit from passive stretches of hamstrings, calf muscles including a range of motion (ROM) exercise to the lower limbs as mat exercises.
Study NCT05097391 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physiotherapy exercise (15 minutes)
Description: The conventional treatments will be active-assisted and free active exercises to the lower limbs on the mat for five (5) minutes. This will be followed by strength training such as sit-to-stand exercises for five (5) minutes and squatting exercises for five (5) minutes prior to the over-ground training.
Study NCT05097391 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy exercise (15 minutes)
Description: The conventional treatments will be active-assisted and free active exercises to the lower limbs on the mat for five (5) minutes. This will be followed by strength training such as sit-to-stand exercises for five (5) minutes and squatting exercises for five (5) minutes prior to the over-ground training.
Study NCT05097391 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Over-ground training with lower limb loading (15-25 minutes)
Description: Participants will perform the over-ground training exercise with an external 1.5kg load on the paretic lower limb placed 2cm above the ankle joint. Before commencing the over-ground training, all the participants will observe a pre-exercise rest period of about two (2) minutes during which their heart rate and blood pressure measurements will be recorded.~The over-ground training will involve the patients walking within a demarcated path. Each participant will be instructed to stand and walk 15meters to and fro for five (5) minutes after which they will be asked to stop and rest for two (2) minutes. The over ground training exercise will be repeated 3 times in the first 2 weeks of the training (15 minutes); 4 times in weeks 3-4 of the training (20 minutes); and 5 times in weeks 5-8 of the training (25 minutes).
Study NCT04749680 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PD cycler Silencia
Description: Treatment for 2 weeks either with PD-Night or Homechoice PD cycler (Comparators) depending on the previous Treatment ((clinical phase I). At the end of these 2 treatment weeks and a subsequent training phase which up to 3 weeks, treatment with the Silencia PD cycler for 2 further weeks (clinical phase II).
Study NCT04702516 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ozempic
Description: 2 mg prefilled pen for subcutaneous injection, 0.25 mg for two weeks then 0.5 mg for two weeks and then 1 mg for another 48 weeks.
Study NCT04702516 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 2 mg prefilled pen for subcutaneous injection, 0.25 mg for two weeks then 0.5 mg for two weeks and then 1 mg for another 48 weeks.
Study NCT06325917 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: what's app ongoing support
Description: daily educational messages and reminders sent through WhatsApp. The educational material related to diabetes self-management behaviors (AADE7 Self-Care Behaviors, diabetes and genetics, and endocrinology center, also the Ministry of Health in Jordan diabetes.~individual bidirectional communication between the participants and the investigator, which will allow participants to seek advice and get free-of-charge feedback and consultation.
Study NCT06325917 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: usual care
Description: monthly visit and follow-up at the diabetes education clinic by a diabetes nurse specialist providing DSMES
Study NCT05261373 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: The Moderate-Intensity Continuous Training (MICT)
Description: 3 sessions per week in a cycle ergometer, with 1-2 days off between sessions, during a total of 12 weeks under the supervision of a personal trainer. MICT program will consist of sessions of approximately ˜45 min of moderate aerobic exercise (at the intensity at which the maximal fat oxidation was achieved in the laboratory test) in cycle ergometer.
Study NCT05261373 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Moderate-Intensity Continuous Training (MICT)
Description: 3 sessions per week in a cycle ergometer, with 1-2 days off between sessions, during a total of 12 weeks under the supervision of a personal trainer. MICT program will consist of sessions of approximately ˜45 min of moderate aerobic exercise (at the intensity at which the maximal fat oxidation was achieved in the laboratory test) in cycle ergometer.
Study NCT05261373 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: The High-Intensity Interval Training (HIIT)
Description: 3 sessions per week in a cycle ergometer, with 1-2 days off between sessions, during a total of 12 weeks under the supervision of a personal trainer. HIIT program will consist of 3-5 series of 1 min duration at 90-130% of its maximum power (determined in the first training session), with 90 seconds of rest between sets (estimated total time of the session: 10 minutes). Depending on the number of training session, the load and the series will increase up to 40% more than the maximum load.
Study NCT05261373 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The High-Intensity Interval Training (HIIT)
Description: 3 sessions per week in a cycle ergometer, with 1-2 days off between sessions, during a total of 12 weeks under the supervision of a personal trainer. HIIT program will consist of 3-5 series of 1 min duration at 90-130% of its maximum power (determined in the first training session), with 90 seconds of rest between sets (estimated total time of the session: 10 minutes). Depending on the number of training session, the load and the series will increase up to 40% more than the maximum load.
Study NCT05261373 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral: Nutritional education program
Description: The education intervention will consist of individual nutritional counselling. The nutritional education program will be conducted every 2 weeks for 12 consecutive weeks, with 20-min counselling sessions by an experienced nutritionist. Participants will be provided with an introduction (in an easy-to-understand manner) regarding the association between T2DM, gut microbiome and dietary habits. Firstly, the diet of the patient should be analysed, to determine which aspects can be improved, such as, total calories intake, amount and types of carbohydrates (highlighting the relevance of fibre), etc. Moreover, some suggestions about the combination of foods and culinary technical in order to manage the glycaemic index of foods will be provided. Finally, those pattern of the Mediterranean diet and some qualitative aspects and aids (as the size of the plat or avoid having the food platter on the table) will be taught the patients.
Study NCT05261373 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Behavioral: Nutritional education program
Description: The education intervention will consist of individual nutritional counselling. The nutritional education program will be conducted every 2 weeks for 12 consecutive weeks, with 20-min counselling sessions by an experienced nutritionist. Participants will be provided with an introduction (in an easy-to-understand manner) regarding the association between T2DM, gut microbiome and dietary habits. Firstly, the diet of the patient should be analysed, to determine which aspects can be improved, such as, total calories intake, amount and types of carbohydrates (highlighting the relevance of fibre), etc. Moreover, some suggestions about the combination of foods and culinary technical in order to manage the glycaemic index of foods will be provided. Finally, those pattern of the Mediterranean diet and some qualitative aspects and aids (as the size of the plat or avoid having the food platter on the table) will be taught the patients.
Study NCT04853966 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity counseling
Description: Physical activity counseling will be performed using physical activity behavior steps of the transtheoretical model.
Study NCT05723952 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Barcelona scoliosis physical therapy school
Description: procedure for treating Adolescent Idiopathic scoliosis
Study NCT05723952 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: International scoliosis schroth therapy
Description: procedure for treating Adolescent Idiopathic scoliosis
Study NCT05667818 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amlodipine besylate tablets (trade name: Norfloxacin ®）
Description: Specification: 5 mg Batch No.: FX3445 Content: 100.2% Expiry date: January 2027 Storage conditions: dark and sealed Manufacturer: Pfizer Inc. Provider: Overseas Pharmaceuticals, Ltd. Take one tablet once a day.
Study NCT05667818 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlodipine besylate controlled-release tablets
Description: Test preparation (T): amlodipine besylate controlled-release tablets Specification: 5 mg Batch No.: 22102501 Content: 100.9% Expiry date: October 24, 2024 Storage conditions: dark, sealed at room temperature. Manufacturer: Overseas Pharmaceuticals, Ltd. Provider: Overseas Pharmaceuticals, Ltd. Take one tablet once a day.
Study NCT06307834 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neurofeedback - based therapy
Description: This intervention will include mental practice of various hand movements accompanied by guided visual feedback, aimed at regulating brain activation patterns to facilitate the restoration of hand movements. We will also incorporate EMG signals to control a hand exoskeleton.
Study NCT06307834 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard hand exercise therapy
Description: This intervention will include engaging in a set of particular hand exercises with the aim of enhancing hand movements.
Study NCT05034835 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: usual treatment with compression garments (CERECARE)
Description: For 3 months, the pain will be assessed every week, tolerance and compliance with compression garments will also be monitored. Participants will be reviewed specifically at a follow-up consultation for the 6-month and 1-year study. Various assessments will be carried out during these visits : assessment of pain, range of motion, muscle strength, sensitivity test, assessment of anxiety, depression and even quality of life.
Study NCT05034835 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: usual treatment without compression garments (CERECARE)
Description: For 3 months, the pain will be assessed every week, tolerance and compliance with compression garments will also be monitored. Participants will be reviewed specifically at a follow-up consultation for the 6-month and 1-year study. Various assessments will be carried out during these visits : assessment of pain, range of motion, muscle strength, sensitivity test, assessment of anxiety, depression and even quality of life.
Study NCT06146777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Intravenous infusion
Study NCT06146777 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intravenous infusion
Study NCT05208359 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Supporting Transition Resilience Of Newcomer Groups (STRONG)
Description: 10 group sessions that offer skills, strengths, support, and affirmation for newcomer youth
Study NCT05208359 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supporting Transition Resilience Of Newcomer Groups (STRONG)
Description: 10 group sessions that offer skills, strengths, support, and affirmation for newcomer youth
Study NCT04879212 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PCIA +Acupuncture group:
Description: Acupuncturing bilateral Zusanli (ST36) and Sanyinjiao (SP6)
Study NCT06085053 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQA3038 injection
Description: TQA3038 is an injection.
Study NCT06085053 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: TQA3038 injection matching placebo
Description: Placebo injection contains no active substance.
Study NCT05656755 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Strengthening
Description: The strengthening exercises were executed with the body weight without any additional weight and were composed of exercises like the squats, the lunges, the plank, and the mountain climbers
Study NCT05656755 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Running
Description: running for two supervised training sessions of one hour, and one free session of 30 minutes per week during 24 weeks
Study NCT05656755 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Running
Description: running for two supervised training sessions of one hour, and one free session of 30 minutes per week during 24 weeks
Study NCT05828004 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Whole-Course Multidisciplinary Care Intervention
Description: On the basis of standard treatment, all patients were evaluated by senior practice nurses in the Department of Oncology in person at the time of enrollment (before radiotherapy) and once every week during radiotherapy, and once in person/over the phone at 1, 2, 3, and 6 months after radiotherapy.
Study NCT05726513 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Weaning trial - Low support, high Positive end-expiratory pressure
Description: The researcher will evaluate the readiness to be weaned of the patient using a weaning trial with low pressure support ventilation and a positive end expiratory pressure of 5 cmH2O